Rheumatology in China: Challenges and development

Rheumatology (United Kingdom)

Volumn 51, Issue 10, 2012, Pages 1733-1734

  Li, Zhanguo ^a   Yang, Yue ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; RITUXIMAB;

ATHEROSCLEROSIS; CHINA; CLINICAL PRACTICE; COHORT ANALYSIS; CONTINUING EDUCATION; DERMATOMYOSITIS; DIAGNOSTIC ERROR; DISEASE ACTIVITY; DISEASE COURSE; EARLY DIAGNOSIS; EDITORIAL; GENE DELETION; GENERAL PRACTITIONER; GENETIC ASSOCIATION; HEART ARRHYTHMIA; HUMAN; LOW DRUG DOSE; MEDICAL EDUCATION; MESENCHYMAL STEM CELL TRANSPLANTATION; POLYMYOSITIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RURAL AREA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TAIWAN; THROMBOCYTOPENIA; URBAN AREA;

CHINA; HUMANS; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84867127894     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes166     Document Type: Editorial

References (12)

1. Zeng QY, Chen R, Darmawan J et al. Rheumatic diseases in China. Arthritis Res Ther 2008;10:R17.
2. Chou CT, Pei L, Chang DM et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994;21:302-6.
3. Li R, Sun J, Ren L et al. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology 2012;51: 721-9.
4. Myasoedova E, Crowson CS, Kremers HM et al. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62:1576-82.
5. Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum 1997;27:123-40.
6. Zhang F. The China rheumatology workforce: a status report. Int J Rheum Dis 2009;12:279-82.
7. Han JW, Zheng HF, Cui Y et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009;41:1234-7.
8. Lu X, Guo J, Zhou X et al. Deletion of LCE3C-LCE3B is associated with rheumatoid arthritis and systemic lupus erythematosus in the Chinese Han population. Ann Rheum Dis 2011;70:1648-51.
9. Li J, Fu Q, Cui H et al. Interferon-a priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-a and atherosclerosis in lupus. Arthritis Rheum 2011;63: 492-502.
10. He J, Guo JP, Ding Y et al. Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome. Rheumatology 2011;50:879-84.
11. Chen H, Zheng W, Su J et al. Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus-a prospective pilot study. Rheumatology 2011;50:1640-4.
12. Wang D, Zhang H, Cao M et al. Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Ann Rheum Dis 2011;70:1285-8.